期刊文献+

10日序贯疗法治疗幽门螺旋杆菌感染疗效观察 被引量:2

原文传递
导出
摘要 目的观察以耐信、阿莫西林、克拉霉素、替硝唑组成的序贯疗法治疗幽门螺旋杆菌感染的疗效。方法行胃镜检查以胃黏膜快速尿素酶检测方法确认为幽门螺旋杆菌感染的患者,随机分组,一组应用序贯疗法进行治疗,对照组应用以耐信、阿莫西林、克拉霉素标准一线方案治疗10d。停药4周后,以14C尿素呼气试验检测判定治疗结局。结果52例序贯疗法组患者治疗10d后,49例幽门螺旋杆菌根治成功,成功率为94.2%,不良反应发生率为11.5%,主要为恶心,症状轻微。对照组60例,47例根治成功,成功率78.3%,不良反应发生率为18.3%。两组患者之间根治成功率有统计学差异,副作用发生率则无统计学差异。结论序贯疗法根治幽门螺旋杆菌感染是一种高效、安全的治疗方案选择。
出处 《中国临床实用医学》 2010年第8期145-147,共3页 China Clinical Practical Medicine
  • 相关文献

参考文献7

  • 1ShallcrossTM, Rathbone B J, Wyatt JI, et al. Helicobacter pylori associated chronic gastritis and peptic ulceration in patients taking non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther, 1990,4(5 ) :515-522.
  • 2Ford A, Moayyedi P. How can the current strategies forHelieobacterpylori eradication therapy be improved. Can J Gastroenterol 2003, (SupplB) :36B-40B.
  • 3Vaira D,ZulloA, VakilN, et al. Sequential therapy versus standard triple-drug therapy forHelicobacter pylori eradication:a randomized trial. Ann InternMed ,2007,146 ( 8 ) :556-563.
  • 4LerroP, KuvidiM, BaldiM, et al. A 10-day sequential therapy : New option forHelicobacter pylori eradication in children. Dig Liver Dis, 2006,38 ( 10 ) : A 104 -A105.
  • 5Cheon JH, Kim N, Lee DH, et al. Trial of moxifloxacin containing triple therapy after initial and second-line treatment failures for helicobacter pylori infection. Korean J Gastroenterol, 2005,45 (2) :111-117.
  • 6Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection:the Maastricht Ⅲ Consensus Report. Gut,2007,56(6) :772-781.
  • 7MurakamiK, Fujioka T, Okimoto T, et al. Drug combinations with amoxicillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int JAntimicrobAgents, 2002, 19(1 ) :67-70.

同被引文献29

  • 1许春娣,刘伟.进一步加强对小儿幽门螺杆菌感染的研究[J].临床儿科杂志,2005,23(10):686-687. 被引量:17
  • 2胡志红,苗芸,肖咏梅,沈鸣.慢性结节状胃炎与幽门螺杆菌的关系[J].实用儿科临床杂志,2006,21(7):412-413. 被引量:10
  • 3张小艳,王曙升,王淑英.幽门螺旋杆菌与胃癌的研究进展[J].现代肿瘤医学,2006,14(8):1028-1030. 被引量:13
  • 4张懋奎.幽门螺杆菌感染的预防对策[J].中国自然医学杂志,2006,8(4):314-316. 被引量:8
  • 5Gisbert JP, Pajares JM. Evolution of Helieobaeter pylori therapy from a meta-analytical perspective[J]. Helicobacter, 2007, 12, 2 (Suppl) : S50-58.
  • 6Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus stan- dard triple-drug therapy for Helicobacter pylori eradication: a ran- domizedtrial[J]. Ann Intern Med, 2007, 146 (8) : 556-563.
  • 7Lerro P, Kuvidi M, Baldi M, et al. A10-day sequential therapy: New option for Helicobacter pylori eradication in children [J]. Dig Liver Dis, 2006, 38 (10): A104-A105.
  • 8C, en E, Calvet X, Azagra R, et al. Triple VS quadruple therapy for treating Helieobaeter pylori infection: an updated meta-analysis [J]. Aliment Pharmaeol Ther, 2003, 18 (2): 543-544.
  • 9Vilaiehone RK, Mahachai V, Graham DY. Helicobacter pyloft di- agnosis and management [J]. Gastroenterol Clin NorthAm, 2006, 35 (2): 229-247.
  • 10Hung IF, Chan P, Leung S, et al. Clarithromycin resistance and efficacy Of clarithromycin-containing triple eradication therapy for Helicobaeter pylori infection in type 2 diabetes mellitus patients [J]. Helieobaeter, 2009, 14: 505-511.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部